| # | Drug | Count |
|---|---|---|
| 0 | CYCLOPHOSPHAMIDE | 9 |
| 1 | CYCLOPHOSPHAMIDE FOR INJECTION | 9 |
| 2 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 9 |
| 3 | DOXORUBICIN | 8 |
| 4 | GEMCITABINE HYDROCHLORIDE | 8 |
| 5 | LENALIDOMIDE | 8 |
| 6 | OXALIPLATIN | 8 |
| 7 | PREDNISONE | 8 |
| 8 | RITUXIMAB | 8 |
| 9 | BENDAMUSTINE HCL | 7 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | BENDAMUSTINE HCL | 7 | 0.0004 |
| 1 | BENDAMUSTINE HYDROCHLORIDE | 2 | 0.0002 |
| 2 | RAMUCIRUMAB | 1 | 0.0002 |
| 3 | GEMCITABINE HYDROCHLORIDE | 8 | 0.0001 |
| 4 | NITROFURANTOIN (MONOHYDRATE/MACROCRYSTALS) | 2 | 0.0001 |
| 5 | DASATINIB | 1 | 0.0001 |
| 6 | OXALIPLATIN | 8 | 0.0001 |
| 7 | AXICABTAGENE CILOLEUCEL | 1 | 0.0001 |
| 8 | DOXORUBICIN | 8 | 0.0001 |
| 9 | CRIZOTINIB | 1 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Vascular Endothelial Growth Factor Receptor 2 Antagonist [EPC] | 1 | 0.0002 |
| 1 | Nitrofuran Antibacterial [EPC] | 2 | 0.0001 |
| 2 | CD19-directed Chimeric Antigen Receptor [EPC] | 1 | 0.0001 |
| 3 | PCSK9 Inhibitor [EPC] | 1 | 0.0000 |
| 4 | Alkylating Drug [EPC] | 9 | 0.0000 |
| 5 | Platinum-based Drug [EPC] | 8 | 0.0000 |
| 6 | CD20-directed Cytolytic Antibody [EPC] | 9 | 0.0000 |
| 7 | Estrogen Receptor Antagonist [EPC] | 1 | 0.0000 |
| 8 | Thalidomide Analog [EPC] | 8 | 0.0000 |
| 9 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 1 | 0.0000 |